| Tretinoin | Approved Investigational Nutraceutical | GPX1 | 2876 |
upregulated | Tretinoin results in increased expression of GPX1 mRNA | 3p21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | GPX2 | 2877 |
upregulated | Tretinoin results in increased expression of GPX2 mRNA | 14q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GPX7 | 2882 |
upregulated | Tretinoin results in increased expression of GPX7 mRNA | 1p32.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GPX8 | 493869 |
upregulated | Tretinoin results in increased expression of GPX8 mRNA | 5q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | GRAMD1C | 54762 |
upregulated | Tretinoin results in increased expression of GRAMD1C mRNA | 3q13.31 | |
| Tretinoin | Approved Investigational Nutraceutical | GRB10 | 2887 |
downregulated | Tretinoin results in decreased expression of GRB10 mRNA | 7p12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | GRB14 | 2888 |
downregulated | Tretinoin results in decreased expression of GRB14 mRNA | 2q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GRB14 | 2888 |
upregulated | Tretinoin results in increased expression of GRB14 mRNA | 2q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GRB7 | 2886 |
downregulated | Tretinoin metabolite results in decreased expression of GRB7 mRNA | 17q12 | |
| Tretinoin | Approved Investigational Nutraceutical | GREB1L | 80000 |
downregulated | Tretinoin results in decreased expression of GREB1L mRNA | 18q11.1-q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | GREM1 | 26585 |
downregulated | Tretinoin results in decreased expression of GREM1 mRNA | 15q13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GREM2 | 64388 |
upregulated | Tretinoin results in increased expression of GREM2 mRNA | 1q43 | |
| Tretinoin | Approved Investigational Nutraceutical | GRHL1 | 29841 |
upregulated | Tretinoin results in increased expression of GRHL1 mRNA | 2p25.1 | |
| Tretinoin | Approved Investigational Nutraceutical | GRIA1 | 2890 |
downregulated | Tretinoin results in decreased expression of GRIA1 mRNA | 5q33.2 | |
| Tretinoin | Approved Investigational Nutraceutical | GRIA3 | 2892 |
downregulated | Tretinoin results in decreased expression of GRIA3 mRNA | Xq25 | |
| Tretinoin | Approved Investigational Nutraceutical | GRIA3 | 2892 |
upregulated | Tretinoin results in increased expression of GRIA3 mRNA | Xq25 | |
| Tretinoin | Approved Investigational Nutraceutical | GRIA4 | 2893 |
upregulated | Tretinoin results in increased expression of GRIA4 mRNA | 11q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GRID1 | 2894 |
downregulated | Tretinoin results in decreased expression of GRID1 mRNA | 10q23.1-q23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | GRIK1 | 2897 |
upregulated | Tretinoin results in increased expression of GRIK1 mRNA | 21q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GRIK2 | 2898 |
upregulated | Tretinoin results in increased expression of GRIK2 mRNA | 6q16.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GRINA | 2907 |
downregulated | Tretinoin results in decreased expression of GRINA mRNA | 8q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GRK3 | 157 |
upregulated | Tretinoin results in increased expression of GRK3 mRNA | 22q12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | GRM3 | 2913 |
downregulated | Tretinoin results in decreased expression of GRM3 mRNA | 7q21.11-q21.12 | |
| Tretinoin | Approved Investigational Nutraceutical | GRM8 | 2918 |
downregulated | Tretinoin results in decreased expression of GRM8 mRNA | 7q31.33 | |
| Tretinoin | Approved Investigational Nutraceutical | GRN | 2896 |
upregulated | Tretinoin results in increased expression of GRN mRNA | 17q21.31 | |